BioSpace News Archive

Business

ConforMIS Reports Preliminary Fourth Quarter and Year-End 2017 Revenue Results; Provides 2018 Financial Guidance

Total revenue of approximately $20.8 million, down 4% year-over-year on a reported basis and 5% on a constant currency basis.

January 9, 2018
·
5 min read
Biotech Bay

Adamas Announces U.S. Commercial Launch of GOCOVRI the First and Only FDA-Approved Medication for the Treatment of Dyskinesia in Parkinson’s Disease Patients

Today’s launch marks the deployment of Adamas’ dedicated team of 59 neurology field sales professionals, who are focused on educating the Parkinson’s disease community about the benefit/safety profile of GOCOVRI.

January 9, 2018
·
8 min read
Bio NC

Micell Technologies’ Positive Five-Year Data Published for MiStent in EuroIntervention

The goal of the two trials was to evaluate long-term clinical results for the MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System..

January 9, 2018
·
3 min read
Business

Baxter to Host Fourth Quarter 2017 Financial Results Conference Call for Investors

Baxter will host a conference call to discuss its fourth quarter 2017 financial results on Thursday, February 1, 2018, at 7:30 a.m. Central Standard Time.

January 9, 2018
·
1 min read
Business

Tandem Diabetes Care Announces Preliminary 2017 Results and Provides 2018 Guidance

Tandem Diabetes Care today reported select, unaudited and preliminary results for the year and quarter ended December 31, 2017.

January 9, 2018
·
8 min read
Business

WuXi AppTec Group and Mayo Clinic Form Joint Venture to Deliver Clinical Diagnostic Services

WuXi AppTec and Mayo Clinic announced today a joint venture to co-develop and deliver clinical diagnostic services in China.

January 9, 2018
·
3 min read
Business

Sarepta Therapeutics Pre-Announces Fourth Quarter 2017 Revenue and Provides Full-Year 2018 Revenue Guidance for EXONDYS 51 (eteplirsen), Representing Approximately 100 Percent Year-Over-Year Growth

EXONDYS 51 revenue guidance for 2018 will be in the range of $295 – $305 million.

January 9, 2018
·
7 min read
Genetown

GC3 Announces Call for Applications for 2018 Startup Technology Showcase

Ten startups will be selected to present their technologies and begin discussions with large companies that could lead to joint development agreements, licensing, investment, and other business opportunities.

January 9, 2018
·
4 min read
Biotech Beach

AmpliPhi Biosciences Announces Proposed Public Offering of Common Stock

AmpliPhi Biosciences today announced that it intends to offer shares of its common stock in a public offering.

January 9, 2018
·
4 min read
Business

Halozyme Projects 25 to 30 Percent ENHANZE Royalty Growth in 2018

Halozyme forecasts 25 to 30 percent royalty revenue growth in 2018 and potential for royalty revenue to reach nearly $1B in 2027 based on the current and expected momentum of partners coformulating products with its ENHANZE technology.

January 9, 2018
·
5 min read